Phathom Pharmaceuticals, Inc. — Form 10-Q
Filed July 30, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
This is a routine quarterly report (10-Q) for Phathom Pharmaceuticals for the period ending June 30, 2026, filed July 30, 2026. The filing document list shows standard SEC exhibits (certification statements, XBRL data) but no substantive business, financial, or strategic details are provided in the header text. Actual operational, financial, and material event disclosures would appear in the full 10-Q body, which is not reproduced here.
Why this rating
Only filing metadata visible; no concrete business events, financial results, guidance changes, or material transactions disclosed in provided text.
See more from July 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.